68Ga-HER2 Affibody PET/CT Imaging for HER2-Positive Cancer Patients

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

December 18, 2021

Primary Completion Date

December 30, 2024

Study Completion Date

December 30, 2025

Conditions
HER2-Positive Cancer
Trial Locations (1)

430030

RECRUITING

TongjiHospital, Wuhan

All Listed Sponsors
lead

Tongji Hospital

OTHER